FDA BLA

WASHINGTON, April 28, 2026 Vanda Pharmaceuticals Inc. has announced the publication of pivotal Phase III clinical data evaluating imsidolimab,...

DUBLIN, IRELAND, April 13, 2026 SynOx Therapeutics has announced positive topline results from its pivotal Phase 3 TANGENT study,...

NOVATO, Calif., April 2, 2026 Ultragenyx Pharmaceutical Inc. has reached a significant regulatory milestone as the U.S. Food and...